Harbin Medisan Pharmaceutical Co Ltd Cash Flow Quality Index
Harbin Medisan Pharmaceutical Co Ltd cash flow quality index. Harbin Medisan Pharmaceutical Co Ltd (002900) has a Cash Flow Quality Index of 1.32x as of September 2024. Operating cash flow of CN¥18.91 Million exceeds net income of CN¥14.31 Million, indicating high earnings quality where cash backs reported profits. Explore 002900 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Harbin Medisan Pharmaceutical Co Ltd (2012–2024)
Cash flow quality index of Harbin Medisan Pharmaceutical Co Ltd from 2012 to 2024. Historical Cash Flow Quality Index for Harbin Medisan Pharmaceutical Co Ltd across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 002900 net asset quality index to measure how much of total assets are equity-financed.
Harbin Medisan Pharmaceutical Co Ltd Cash Flow Quality Index by Year (2012–2024)
Harbin Medisan Pharmaceutical Co Ltd cash flow quality index by year from 2012 to 2024. Year-by-year earnings quality comparison for Harbin Medisan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 002900 cash generation efficiency.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.56x | CN¥30.69 Million | CN¥54.98 Million | ▲ +15.2% |
| 2023 | 0.48x | CN¥35.69 Million | CN¥73.66 Million | ▼ -91.1% |
| 2022 | 5.46x | CN¥144.64 Million | CN¥26.50 Million | ▲ +15326.1% |
| 2021 | -0.04x | CN¥-12.53 Million | CN¥349.68 Million | ▲ +78.8% |
| 2020 | -0.17x | CN¥-4.51 Million | CN¥26.63 Million | ▼ -109.2% |
| 2019 | 1.84x | CN¥320.14 Million | CN¥173.86 Million | ▲ +28.7% |
| 2018 | 1.43x | CN¥292.46 Million | CN¥204.39 Million | ▲ +16.0% |
| 2017 | 1.23x | CN¥223.46 Million | CN¥181.08 Million | ▼ -6.5% |
| 2016 | 1.32x | CN¥231.18 Million | CN¥175.18 Million | ▲ +9.3% |
| 2015 | 1.21x | CN¥200.85 Million | CN¥166.30 Million | ▲ +52.6% |
| 2014 | 0.79x | CN¥116.31 Million | CN¥146.98 Million | ▼ -50.6% |
| 2013 | 1.60x | CN¥167.10 Million | CN¥104.39 Million | ▲ +7.5% |
| 2012 | 1.49x | CN¥123.22 Million | CN¥82.72 Million | — |